Shared on 10 Nov 25
Fair value Decreased 0.035%MOVE: Revenue Will Hold Steady as Earnings Guidance Signals Further Upside
Narrative Update: Medacta Group Price Target Adjustment Analysts have slightly lowered their fair value estimate for Medacta Group from CHF164.46 to CHF164.40, citing minor model updates that reflect changes in discount rate assumptions. What's in the News Medacta Group SA confirmed its earnings guidance for 2025, targeting revenue growth of 16% to 18% in constant currency, subject to unforeseen events (Company Guidance).
Shared on 27 Oct 25
Fair value Increased 4.81%Analysts have raised their price target for Medacta Group from CHF156.91 to CHF164.46, citing modest adjustments to growth and margin expectations as reflected in updated forecasts. What's in the News Medacta Group SA confirmed its earnings guidance for 2025, targeting revenue growth in the range of 16% to 18% in constant currency, subject to unforeseen events (Key Developments).
Shared on 04 Aug 25
Fair value Increased 7.95%Medacta Group's higher consensus price target reflects improved sentiment driven by a modest increase in net profit margin and a slight decrease in the future P/E ratio, raising fair value estimates from CHF145.35 to CHF153.91. What's in the News Medacta Group will hold its H1 2025 Sales/Trading Statement Call on July 31, 2025.
Shared on 23 Apr 25
Fair value Decreased 1.67%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Fair value Increased 0.45%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Increased 2.75%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Decreased 3.26%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Decreased 6.21%AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.
Shared on 19 Mar 25
Fair value Increased 0.82%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Increased 4.33%AnalystConsensusTarget has increased revenue growth from 13.2% to 14.6% and increased shares outstanding growth rate from -0.0% to 0.0%.